Exchange: NASDAQ·Updated 07:30 PM EDT
AVIR logo

AVIR Atea Pharmaceuticals Inc

$5.43
$0.08
(1.45%)
Today
Closed $5.43
$0.00
(0.00%)
After Hours
Reported EarningsAug 12
Mkt Cap$441.93M
Vol198,065.00

About AVIR

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
43

Bearish Sentiment

How do you feel about AVIR?

Advertisement|Remove ads.